logo

BIIB

Biogen·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

BIIB fundamentals

Biogen (BIIB) released its earnings on Oct 30, 2025: revenue was 2.53B (YoY +2.76%), beat estimates; EPS was 4.81 (YoY +17.89%), beat estimates.
Revenue / YoY
2.53B
+2.76%
EPS / YoY
4.81
+17.89%
Report date
Oct 30, 2025
BIIB Earnings Call Summary for Q3,2025
  • Launch Product Dominance: LEQEMBI (+82% global sales) and ZURZUVAE (+19% U.S. growth) drive 67% YoY revenue increase in launch portfolio.
  • Pipeline Momentum: 10 Phase III programs, including Felzartamab (80% AKI resolution in lupus) and BIIB080 (tau ASO with potential combination therapies).
  • Immunology Focus: Strategic shift to rare immunology with 25%+ pipeline allocation, leveraging MS expertise in kidney and lupus indications.
  • Financial Strength: $1.2B free cash flow, $4B cash balance, and on-track $1B gross savings target.
  • Access Expansion: LEQEMBI subcutaneous maintenance approved in 34 countries, Sky Claris launched in 34 markets with 50%+ new writers.
EPS
Revenue

Revenue & Expenses

BIIB has released its 2025 Q3 earnings report, with revenue of 2.53B, reflecting a YoY change of 2.79%, and net profit of 466.50M, showing a YoY change of 20.08%. The Sankey diagram below clearly presents BIIB's revenue sources and cost distribution.

Key Indicators

Biogen (BIIB) key financial stats and ratios, covering profitability, financial health, and leverage.
Biogen (BIIB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biogen (BIIB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biogen (BIIB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biogen (BIIB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biogen (BIIB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield